Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DIVIS LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
TEVA PHARMA
Dec-13
DIVIS LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6413,479-   
Low Rs2,7303,022-   
Sales per share (Unadj.) Rs292.61,996.4-  
Earnings per share (Unadj.) Rs68.7124.7-  
Cash flow per share (Unadj.) Rs81.6286.1-  
Dividends per share (Unadj.) Rs30.00109.18-  
Avg Dividend yield %0.83.4 24.2%  
Book value per share (Unadj.) Rs480.92,217.6-  
Shares outstanding (eoy) m265.47848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.61.6 773.7%   
Avg P/E ratio x53.726.1 205.9%  
P/CF ratio (eoy) x45.211.4 397.5%  
Price / Book Value ratio x7.71.5 522.9%  
Dividend payout %43.787.5 49.9%   
Avg Mkt Cap Rs m978,3782,756,220 35.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m9,7500-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m77,6751,692,969 4.6%  
Other income Rs m3,4470-   
Total revenues Rs m81,1221,692,969 4.8%   
Gross profit Rs m23,691463,620 5.1%  
Depreciation Rs m3,432136,844 2.5%   
Interest Rs m2033,253 0.1%   
Profit before tax Rs m23,686293,523 8.1%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m5,453-3,584 -152.2%   
Profit after tax Rs m18,234105,758 17.2%  
Gross profit margin %30.527.4 111.4%  
Effective tax rate %23.0-1.2 -1,885.5%   
Net profit margin %23.56.2 375.8%  
BALANCE SHEET DATA
Current assets Rs m97,4371,143,425 8.5%   
Current liabilities Rs m15,331997,163 1.5%   
Net working cap to sales %105.78.6 1,223.5%  
Current ratio x6.41.1 554.3%  
Inventory Days Days891 9.2%  
Debtors Days Days84296 878.2%  
Net fixed assets Rs m51,128552,961 9.2%   
Share capital Rs m5314,167 12.7%   
"Free" reserves Rs m127,1400-   
Net worth Rs m127,6711,880,567 6.8%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m148,5653,868,976 3.8%  
Interest coverage x1,209.59.8 12,307.7%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 119.5%   
Return on assets %12.33.6 342.0%  
Return on equity %14.35.6 254.0%  
Return on capital %18.64.9 376.5%  
Exports to sales %85.70-   
Imports to sales %19.80-   
Net fx Rs m50,8220-   
CASH FLOW
From Operations Rs m24,597269,772 9.1%  
From Investments Rs m-27,076-95,591 28.3%  
From Financial Activity Rs m-7,972-323,609 2.5%  
Net Cashflow Rs m-10,451-149,429 7.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare DIVIS LABORATORIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare DIVIS LABORATORIES With: KWALITY PHARMA  EMMESSAR CHM  BAFNA PHARMA  HESTER BIOSCIENCES  NGL FINE CHM  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.